CLuB PhD Candidate Ms Faye Lewis presenting her posters at the 2024 Annual Global Meeting of the International Gynecologic Cancer Society, The Convention Centre, Dublin.
CLuB Co-Investigator Dr Sharon O’Toole and CLuB Esteemed Colleague Dr Mark Ward also presented their work on the use of ctDNA in ovarian cancer at the 2024 Annual Global Meeting of the International Gynecologic Cancer Society.
Club Co-Investigator Dr. Sharon O’Toole is recognised for her hard work bringing the patient voice to the center of the 2024 Annual Global Meeting of the International Gynecologic Cancer Society. Well done Dr O’Toole!
Previous
Previous
CLuB Founder & Lead Investigator is an Invited Speaker at the First Conference on Targeting Extracellular Vesicles, Corinthia Palace, Malta.
Next
Next